All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know AML.
The AML Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the AML Hub cannot guarantee the accuracy of translated content. The AML Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
To help navigate the exciting content being presented at the 64th American Society of Hematology (ASH) Annual Meeting & Exposition, the AML Hub Steering Committee members have provided their recommendations for the top abstracts to look out for in acute myeloid leukemia, in five categories: Novel therapeutic agents; practice-changing abstracts; biomarkers and molecular profiling; induction and consolidation regimens; and minimal residual disease (MRD) assessment and utility.
Subscribe to get the best content related to AML delivered to your inbox